U.S. Logistics Stock News

In recent days, XPO has drawn attention as institutional investors sold deeply out-of-the-money put options ahead of its Q4 2025 earnings, while the company’s North American Less-Than-Truckload business continued to gain share with firm pricing despite a soft freight backdrop. Alongside this, XPO announced that two of its drivers were selected as Captains for the 2026–2027 America’s Road Team, underscoring the company’s emphasis on safety, leadership, and industry advocacy. With this...

Magyar Bancorp (MGYR) has just wrapped up Q1 2026 with Q4 2025 numbers that show total revenue of US$9.0 million and basic EPS of US$0.41, backed by net income of US$2.5 million. Over the past year, the bank has seen revenue range between US$7.2 million and US$9.3 million per quarter while EPS moved between roughly US$0.27 and US$0.43, with trailing 12 month EPS reported at about US$1.57. With a trailing net profit margin of 27.7% compared with 24.7% a year earlier, the latest results keep...

Robert Half Inc. has reported fourth-quarter 2025 results, with net income of US$31.76 million and diluted earnings per share of US$0.32 from continuing operations, both lower than a year ago but ahead of analyst expectations. Management highlighted the first positive sequential growth in talent solutions and enterprise revenues on a same-day constant currency basis in over three years, underpinned by ongoing investment in AI-powered platforms and recent senior leadership promotions in data...

Cohen & Steers (CNS) has drawn fresh attention after recent share performance diverged between shorter and longer timeframes, with a modest gain over the past month contrasting with weaker moves across the past 3 months and year. See our latest analysis for Cohen & Steers. At a latest share price of US$64.26, Cohen & Steers has paired a 30 day share price return of 2.36% with a year long total shareholder return decline of 25.10%. This suggests recent momentum is still trying to recover from...

In recent days, IREN has been in focus as it accelerates a pivot from bitcoin mining toward AI-focused data center services, underpinned by a long-term US$9.70 billion cloud capacity agreement with Microsoft. This shift, reinforced by Anthropic’s very large funding round and rising demand for high-performance computing, is recasting IREN as a key AI infrastructure partner rather than a pure crypto miner. We’ll now examine how this Microsoft-backed AI infrastructure expansion is reshaping...

Why Enpro is on investors’ radar today Enpro (NPO) has attracted fresh attention after recent trading, with the stock last closing at $238.78. Investors are weighing this price against the company’s financial profile and recent return pattern. See our latest analysis for Enpro. While Enpro’s share price slipped 0.5% in the last session, the 11.5% 1 month share price return and 8.9% year to date share price return sit alongside a 29.4% 1 year total shareholder return and 233.5% 5 year total...

Brookfield Infrastructure (NYSE:BIPC) has just posted another quarter of mixed results, with Q3 FY 2025 revenue of US$917 million, basic EPS of US$0.69 and net income of US$82 million, set against a trailing twelve month loss of US$156 million on revenue of US$3.7 billion and basic EPS of US$1.31 loss. Over recent quarters, revenue has hovered in a tight band between US$866 million and US$944 million, while basic EPS has swung from a loss of US$6.83 in Q3 FY 2024 to a profit of US$3.27 in Q1...

Schrödinger (SDGR) is back in focus as its physics based computational platform, high profile collaborations including Novartis Pharma AG, and favorable analyst endorsements draw fresh attention from investors following recent coverage. See our latest analysis for Schrödinger. Despite the recent attention around its platform and collaborations, Schrödinger’s share price has come under pressure, with a 7 day share price return of 14.92% and a 30 day share price return of 21.87%, contributing...

Apple (NasdaqGS:AAPL) is acquiring AI startup Q.ai in a multi billion dollar deal, signaling a push into advanced AI powered features. The company is seeing high profile departures from its AI leadership team while deepening its partnership with Google on Gemini AI for next generation Siri. These moves come alongside record breaking iPhone and Services revenue and a planned collaboration with Intel to use its fabs for future chip production. For you as an investor watching Apple, the Q.ai...

Regeneron Pharmaceuticals (REGN) has put up another busy quarter, with Q3 FY 2025 revenue of US$3.8b and basic EPS of US$14.09 alongside net income of US$1,460m, all against a backdrop where trailing 12 month EPS sits at US$43.30 on revenue of US$14.2b. The company has seen revenue move from US$3.5b in Q2 FY 2024 to US$3.8b in Q3 FY 2025, while quarterly EPS has shifted from US$13.25 to US$14.09 over the same span. This gives investors a clear look at how top line and per share earnings have...

Why Norfolk Southern Is Back on Investors’ Radar Norfolk Southern (NSC) is drawing fresh attention after recent share performance and updated fundamental data, giving investors new context for assessing this large U.S. rail operator’s role in their portfolios. See our latest analysis for Norfolk Southern. Recent trading has been relatively steady, with the 90 day share price return of 2.77% and a 1 year total shareholder return of 16.52% suggesting momentum has been gradually building rather...

If you are looking at Option Care Health and wondering whether the current share price lines up with its underlying value, this article is designed to walk you through that question step by step. The stock last closed at US$34.00, with returns of 6.7% over 30 days, 5.5% year to date and 10.0% over 1 year, which may catch your eye if you are weighing up growth potential against risk. Over longer periods, Option Care Health has recorded returns of 18.5% over 3 years and 70.9% over 5 years...

Earlier this week, CRA International reported quarterly results showing 10.8% year-on-year revenue growth and earnings and revenue above analyst estimates, and also announced that antitrust economist Margaret (Peggy) Loudermilk has joined as a Vice President in its Antitrust & Competition Economics Practice. The combination of stronger-than-expected financial performance and the addition of a veteran U.S. Department of Justice antitrust leader materially reinforces CRA’s profile in complex...

If you are wondering whether Teva Pharmaceutical Industries is priced for further gains or already reflecting most of the good news, starting with a clear look at its current valuation can help you frame that question. Teva’s share price closed at US$34.08, with returns of 7.1% over 7 days, 9.2% over 30 days, 10.1% year to date, 92.2% over 1 year, 216.7% over 3 years and 178.4% over 5 years. This naturally raises questions about what is already built into the price and what might still be on...

Nelnet, Inc. recently declared a first-quarter cash dividend of US$0.33 per share on its Class A and Class B common stock, payable on March 13, 2026, to shareholders of record as of February 27, 2026. This dividend decision comes alongside 18% annual revenue growth over the past two years, sustained share buybacks, and a return on equity of 10.7%, highlighting a multifaceted approach to rewarding shareholders. Next, we will examine how Nelnet’s combination of robust revenue growth and...

Nexa Resources (NYSE:NEXA) has temporarily suspended operations at its Atacocha San Gerardo mine. The halt follows a road blockade by members of the local community protesting near the site. The mine is currently operating with a minimum workforce focused on critical services and maintenance. Nexa Resources enters this disruption with the stock at $12.61 after a strong run, including a 42.5% return over the past 30 days and 43.5% year to date. Over the past year, NYSE:NEXA has returned...

Definium Therapeutics (NasdaqGS:DFTX) appointed veteran biopharmaceutical executive Roger Adsett to its Board of Directors. Adsett brings extensive experience in commercial strategy, operations, and the launch of multiple therapies. The appointment comes as Definium Therapeutics prepares for three anticipated Phase 3 readouts. For you as an investor, the key point is that Definium Therapeutics operates in the biopharmaceutical space, where late stage clinical milestones can be important...

GCL Global Holdings (NasdaqGS:GCL) has just posted its H1 2026 scorecard, with H2 2025 revenue at about US$91.2 million and basic EPS of US$0.03, while the trailing twelve months show revenue of roughly US$142.1 million and basic EPS of US$0.05 as the group moved from earlier losses into profit. The company has seen revenue move from US$97.5 million to US$142.1 million over the trailing periods shown, with EPS shifting from small losses to positive figures. In this context, the latest half...

If you are wondering whether Owens Corning shares are offering good value today, it helps to first line up the recent price moves with what the underlying estimates and balance sheet are telling you. The stock last closed at US$119.84, with returns of 7.1% over the past 30 days, 5.0% year to date, a 33.6% decline over the last year, and gains of 25.3% and 58.8% over the past 3 and 5 years respectively. This performance may leave you questioning whether the current price still reflects...

Equinix has attracted renewed attention after major banks issued supportive research and AI-focused customers deployed high-density and sovereign AI infrastructure across its NY5 and SY5 data centers, underscoring strong demand for its interconnection and colocation services. The launch of Australia’s first sovereign AI node at Equinix SY5 highlights how regulatory needs like data residency are becoming a powerful growth driver for specialized data center infrastructure. We’ll now examine...

If you are wondering whether PriceSmart's recent share price puts it on sale or at a premium, you are in the right place for a clear look at what the current price could mean for you. PriceSmart shares last closed at US$142.21, with returns of 1.1% over 7 days, 15.9% over 30 days, 15.3% year to date, 58.3% over 1 year, and 100.4% over 3 years, compared with 53.8% over 5 years. Recent attention on PriceSmart has been shaped by ongoing coverage of its membership warehouse model in Latin...

Klaviyo (KVYO) is back in focus after launching a Klaviyo app in ChatGPT and welcoming Wunderkind to its marketplace, a pair of AI focused integrations that sharpen its marketing data and personalization toolkit. See our latest analysis for Klaviyo. These AI integrations arrive after a tough stretch for the stock, with a 7 day share price return of a 13.31% decline, a 30 day share price return of a 31.60% decline and a 1 year total shareholder return of a 51.73% decline. This suggests recent...

If you are wondering whether Arbor Realty Trust is a bargain or a value trap after a rough stretch in the market, this article will walk you through what the numbers actually say about the stock. The share price closed at US$7.70 recently, with returns of a 0.5% decline over 7 days, a 0.8% decline over 30 days and a 3.1% decline year to date, alongside a 35.0% decline over 1 year, a 27.5% decline over 3 years and a 14.7% decline over 5 years. Recent headlines around Arbor Realty Trust have...

Boston Scientific (NYSE:BSX) recently completed its acquisition of Nalu Medical, expanding its presence in pain management devices. The company has also announced a pending US$14.5b deal to acquire Penumbra, which would extend its reach into neurovascular therapies. Together, these moves mark a shift in Boston Scientific's portfolio mix toward large, high-growth medical technology segments. Boston Scientific is already a major player in cardiovascular and other interventional medical...